[
  {
    "rank": 1,
    "doc_id": 2248,
    "score_rrf": 0.032018442622950824,
    "text": "Copyright © Extracorporeal Life Support Organization. Unauthorized reproduction of this article is prohibited. CLINICAL GUIDELINES FOR ROUTINE NEUROMONITORING 899 interventions and potentially improve outcomes. This guideline provides recommendations based on currently available evidence. Figure 1 and the key recommendations below provide a summary of the recommendations for patients supported on ECMO and for specific high-risk groups. Limitations and barriers to implement the above recommendations may include resource constraints and training required for successful implementation.",
    "meta": {
      "source": "clinical_guidelines_for_routine_neuromonitoring_in.1.txt",
      "file_name": "clinical_guidelines_for_routine_neuromonitoring_in.1.txt",
      "page": 5,
      "year": 2023,
      "section": "",
      "doc_type": "guideline",
      "pediatric": true,
      "single_ventricle": false
    }
  },
  {
    "rank": 2,
    "doc_id": 2378,
    "score_rrf": 0.030679156908665108,
    "text": "Bias In Non-randomized Studies of Interventions (ROBINS-I) tool for nonrandomized studies (25, 26). Key data elements were extracted using electronic forms developed in the Research Data Electronic Capture (REDCap) browser (27) and exported into evidence tables. The protocol for the systematic reviews was registered on the International Prospective Register of Systematic Reviews (CRD42021236582). Different types of recommendation or statements were generated (Table 2). The GRADE approach was used to summarize relevant evidence and develop recommendations for clinical practice (28, 29).",
    "meta": {
      "source": "executive_summary_of_the_second_international.8.txt",
      "file_name": "executive_summary_of_the_second_international.8.txt",
      "page": 4,
      "year": 2023,
      "section": "",
      "doc_type": "guideline",
      "pediatric": true,
      "single_ventricle": false
    }
  },
  {
    "rank": 3,
    "doc_id": 2390,
    "score_rrf": 0.030017921146953404,
    "text": "ible PARDS” for children on nasal modes of support such as HFNC, and enabling modifications for RLS. Tables 6–9 summarize PALICC-2 recommendations and statements in the context of a patient’s trajectory from diagnosis to follow-up. Section 1. Definition, Incidence, and Epidemiology (14) Age. Definition statement 1.1. All patients less than 18 years old without active perinatal lung disease should be diagnosed with PARDS using PALICC-2 criteria. (Ungraded DS, 94% agreement) (14).",
    "meta": {
      "source": "executive_summary_of_the_second_international.8.txt",
      "file_name": "executive_summary_of_the_second_international.8.txt",
      "page": 5,
      "year": 2023,
      "section": "",
      "doc_type": "guideline",
      "pediatric": true,
      "single_ventricle": false
    }
  },
  {
    "rank": 4,
    "doc_id": 2203,
    "score_rrf": 0.029211087420042643,
    "text": "ny decision made or action taken in reliance upon the information provided through these guidelines. Key Words: ECMO, neuromonitoring, guideline, pediatrics, neonatesFGROUPGuidelines Neurologic injury is a major contributor to morbidity and mortality in children on extracorporeal membrane oxygenation (ECMO) support.1–3 The incidence of neurologic complications in neonates and children on ECMO support has been reported to be between 12% and 52%.2–5 Risk factors for neurologic injury during ECMO include underlying patient-related factors such as prematurity, lower body weight, congenital heart disease, cardiac failure, pre-ECMO cardiac arrest, acidosis, hypoxemia, hypocarbia, hypotension, and impairment of cerebral autoregulation.",
    "meta": {
      "source": "clinical_guidelines_for_routine_neuromonitoring_in.1.txt",
      "file_name": "clinical_guidelines_for_routine_neuromonitoring_in.1.txt",
      "page": 1,
      "year": 2023,
      "section": "",
      "doc_type": "guideline",
      "pediatric": true,
      "single_ventricle": false
    }
  },
  {
    "rank": 5,
    "doc_id": 2213,
    "score_rrf": 0.029957522915269395,
    "text": "rophysiologic monitoring such as intermittent or continuous EEG (cEEG), SSEP, and cerebral oximetry. The aim of this clinical guideline for routine neuromonitoring in neonatal and pediatric patients supported on ECMO was to review current literature and provide guidance for healthcare professionals who manage neonatal and pediatric patients supported on ECMO.",
    "meta": {
      "source": "clinical_guidelines_for_routine_neuromonitoring_in.1.txt",
      "file_name": "clinical_guidelines_for_routine_neuromonitoring_in.1.txt",
      "page": 2,
      "year": 2023,
      "section": "",
      "doc_type": "guideline",
      "pediatric": true,
      "single_ventricle": false
    }
  },
  {
    "rank": 6,
    "doc_id": 2105,
    "score_rrf": 0.029083245521601686,
    "text": "maternal risk factors are prenatal/ gestational diabetes, and a history of β‐blocker use (Table 3). The guideline PES2 mainly focuses on the evaluation and management of persistently hypoglycemic newborns, so no relevant preventive measures are listed. Among the remaining guidelines, early initiation of breastfeeding, ≤3 h between feedings, and early mother‐infant skin‐to‐skin contact (SSC) are the most common preventive measures.",
    "meta": {
      "source": "Clinical Endocrinology - 2023 - Luo - Systematic review of guidelines on neonatal hypoglycemia.txt",
      "file_name": "Clinical Endocrinology - 2023 - Luo - Systematic review of guidelines on neonatal hypoglycemia.txt",
      "page": 4,
      "year": 2023,
      "section": "",
      "doc_type": "guideline",
      "pediatric": true,
      "single_ventricle": false
    }
  }
]